首页> 外文会议>Postdoctoral Symposium for Celebration of 20th Anniversary of the Foundation of Chinese Postdoctoral System; 2005; >Identification and significance of differential proteins in A549 cells transfected with HLCDG1
【24h】

Identification and significance of differential proteins in A549 cells transfected with HLCDG1

机译:转染HLCDG1的A549细胞中差异蛋白的鉴定及意义

获取原文
获取原文并翻译 | 示例

摘要

HLCDG1, which locates in chromosome 5q33, is a novel gene cloned recently. The HLCDG1 expression was significantly down regulated in the primary lung carcinoma. It was previously studied that HLCDG1 acted like a tumor suppressor gene. In this paper, proteomics studies were performed to analyze the proteomic expression patterns in the HLCDG1-transfected human lung carcinoma cell line (A549-HLCDG1) and in the control vector-trans-fected human lung carcinoma cell line (A549-vector). Employing two dimensional gel electrophoresis (2DE), the global pattern of protein expressions in A549-HLCDG1 human lung adenocarcinoma cell line expressing stably HL-CDG1 gene were compared with those of control A549-vector cell line to generate a differential protein expression catalog. Forty-two differentially expressed proteins were screened. Thirteen differential proteins were identified by matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF-MS), which were 6 up-regulated (MSH5, MOD, MDH precursor, ETFβ, Prxd Ⅵ and JM23) and 7 downregulated (PLC-δ1, hnRNPA2, hnRNPB1, TIM, TCTP, nm23H—1 and Prxd Ⅴ) proteins in A549-HLCDG1 cells compared to control A549-vec-tor cells. The above identified proteins were involved in energy metabolism, transcription regulation, antioxidation, cell cycle, metastasis, DNA methylation and mismatch repair. Therefore, these differential expression proteins by HLCDG1 transfection may play some important roles for investigation of the biochemical basis of growth suppression of HLCDG1 gene in lung carcinoma cells A549. Further understanding of this data base may provide valuable resources for the developing novel diagnostic markers and therapeutic targets of lung cancer.
机译:HLCDG1位于5q33号染色体,是最近克隆的一个新基因。在原发性肺癌中,HLCDG1表达明显下调。以前曾研究过HLCDG1的作用类似于抑癌基因。在本文中,进行了蛋白质组学研究,以分析在HLCDG1转染的人肺癌细胞系(A549-HLCDG1)和在对照载体转染的人肺癌细胞系(A549-vector)中的蛋白质组表达模式。使用二维凝胶电泳(2DE),将稳定表达HL-CDG1基因的A549-HLCDG1人肺腺癌细胞系中的蛋白表达的整体模式与对照A549-载体细胞系中的蛋白表达模式进行比较,以生成差异蛋白表达目录。筛选了42种差异表达的蛋白质。通过基质辅助激光解吸/电离飞行时间质谱(MALDI-TOF-MS)鉴定了13种差异蛋白,其中6种上调蛋白质(MSH5,MOD,MDH前体,ETFβ,PrxdⅥ和JM23)和7种下调蛋白质与对照A549-vec-tor细胞相比,A549-HLCDG1细胞中的(PLC-δ1,hnRNPA2,hnRNPB1,TIM,TCTP,nm23H-1和PrxdⅤ)蛋白。以上鉴定的蛋白质参与能量代谢,转录调节,抗氧化,细胞周期,转移,DNA甲基化和错配修复。因此,这些通过HLCDG1转染的差异表达蛋白可能在研究肺癌细胞A549中HLCDG1基因的生长抑制的生化基础中起重要作用。对该数据库的进一步理解可以为开发新型的肺癌诊断标记和治疗靶标提供有价值的资源。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号